 AstraZeneca PLC LSE:AZN said it has sold its manufacturing site in West Chester, Ohio to National Resilience, Inc., which plans to expand the site and support future growth of its medicines manufacturing capabilities. As part of our long-term strategy to ensure our global supply network remains fit for the future, we are continuously optimising our manufacturing footprint to meet the evolving needs of our pipeline and portfolio, commented Andrew Wirths, senior vice president of AstraZenecas Americas Supply Region. 